Skip to Main Content

Author Details

Xiaogang Wen
Centro Hospitalar Universitario do Porto (CHUP).
2009
22
15
PMIDPaper TitleJournal TitlePublished Year
37366224Role of Endoscopic Biopsies and Morphologic Features in Predicting Microsatellite Instability Status in Gastric Cancer: A Multicenter Comparative Study of Endoscopic Biopsies and Surgical Specimens.Am J Surg Pathol2023
37271124Performance of Immunohistochemical and Molecular Methods in Detecting Microsatellite Instability in Gastric Cancer: A Multicenter Study.Pathobiology2023
37366224Role of Endoscopic Biopsies and Morphologic Features in Predicting Microsatellite Instability Status in Gastric Cancer: A Multicenter Comparative Study of Endoscopic Biopsies and Surgical Specimens.Am J Surg Pathol2023
37271124Performance of Immunohistochemical and Molecular Methods in Detecting Microsatellite Instability in Gastric Cancer: A Multicenter Study.Pathobiology2023
36612071EBV and MSI Status in Gastric Cancer: Does It Matter?Cancers (Basel)2022
36612071EBV and MSI Status in Gastric Cancer: Does It Matter?Cancers (Basel)2022
33572915Expression of Thomsen-Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability.Int J Mol Sci2021
33572915Expression of Thomsen-Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability.Int J Mol Sci2021
29454568Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease.Gastrointest Endosc2018
30014492Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management.Histopathology2018
29454568Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease.Gastrointest Endosc2018
30014492Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management.Histopathology2018
25740226Interleukin-1B signalling leads to increased survival of gastric carcinoma cells through a CREB-C/EBPβ-associated mechanism.Gastric Cancer2016
25740226Interleukin-1B signalling leads to increased survival of gastric carcinoma cells through a CREB-C/EBPβ-associated mechanism.Gastric Cancer2016
26741353Ingestion of a natural mineral-rich water in an animal model of metabolic syndrome: effects in insulin signalling and endoplasmic reticulum stress.Horm Mol Biol Clin Investig2016
27087319Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Am J Hum Genet2016
26401027Helicobacter pylori cagA Promoter Region Sequences Influence CagA Expression and Interleukin 8 Secretion.J Infect Dis2016
26401027Helicobacter pylori cagA Promoter Region Sequences Influence CagA Expression and Interleukin 8 Secretion.J Infect Dis2016
26741353Ingestion of a natural mineral-rich water in an animal model of metabolic syndrome: effects in insulin signalling and endoplasmic reticulum stress.Horm Mol Biol Clin Investig2016
27087319Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Am J Hum Genet2016
26144047Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways.Biochim Biophys Acta2015
26144047Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways.Biochim Biophys Acta2015
23887584First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile.Virchows Arch2013
23887584First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile.Virchows Arch2013
21813476Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome.Gut2012
22548492First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia.Aliment Pharmacol Ther2012
21813476Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome.Gut2012
22157086Association between environmental factors and CDX2 expression in gastric cancer patients.Eur J Cancer Prev2012
21989054E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2.Hum Mol Genet2012
22548492First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia.Aliment Pharmacol Ther2012
21989054E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2.Hum Mol Genet2012
22157086Association between environmental factors and CDX2 expression in gastric cancer patients.Eur J Cancer Prev2012
20386538C/EBP alpha expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis.Lab Invest2010
20856229De novo expression of CD44 variants in sporadic and hereditary gastric cancer.Lab Invest2010
20386538C/EBP alpha expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis.Lab Invest2010
20452684Helicobacter pylori colonization of the adenotonsillar tissue: fact or fiction?Int J Pediatr Otorhinolaryngol2010
20856229De novo expression of CD44 variants in sporadic and hereditary gastric cancer.Lab Invest2010
20452684Helicobacter pylori colonization of the adenotonsillar tissue: fact or fiction?Int J Pediatr Otorhinolaryngol2010
19269290Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.Gastroenterology2009
19408054Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.Ann Surg Oncol2009
19403558The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin.Hum Mol Genet2009
19403558The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin.Hum Mol Genet2009
19408054Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.Ann Surg Oncol2009
19269290Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.Gastroenterology2009
  • 1 - 44 of 44

Recommended Authors

Institute of Pathology, Heidelberg University Hospital
Career Start Year 2017
Number of shared co-authors 0
Institute of Pathology, University Medical Center Mannheim, University of Heidelberg
Career Start Year 2012
Number of shared co-authors 2
Maastricht University Medical Center.
Career Start Year 2007
Number of shared co-authors 0
Research Institute, National Center for Global Health and Medicine
Career Start Year 2001
Number of shared co-authors 1
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 2
Regeneron Pharmaceuticals Inc.
Career Start Year 2000
Number of shared co-authors 0
Research Institute, National Cancer Center
Career Start Year 1998
Number of shared co-authors 0
. Fred Hutchinson Cancer Center
Career Start Year 1997
Number of shared co-authors 6
General Hospital of Tibet Area Military Command
Career Start Year 1997
Number of shared co-authors 0
Maastricht University Medical Center
Career Start Year 1996
Number of shared co-authors 0
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 4
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 3
Antwerp University Hospital
Career Start Year 1993
Number of shared co-authors 1
Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine
Career Start Year 1993
Number of shared co-authors 0
The Netherlands Cancer Institute
Career Start Year 1993
Number of shared co-authors 0
Nova Scotia Health Authority
Career Start Year 1992
Number of shared co-authors 3
The Netherlands Cancer Institute
Career Start Year 1992
Number of shared co-authors 1
Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg
Career Start Year 1991
Number of shared co-authors 1
Brown University, Rhode Island Providence VA Medical Center
Career Start Year 1991
Number of shared co-authors 0
Seoul National University College of Medicine
Career Start Year 1991
Number of shared co-authors 0
Mount Sinai Hospital
Career Start Year 1990
Number of shared co-authors 4
School of Public Health, Imperial College London
Career Start Year 1990
Number of shared co-authors 5
University of Sydney
Career Start Year 1989
Number of shared co-authors 15
Mt Sinai Hospital
Career Start Year 1988
Number of shared co-authors 8
Division of Gastroenterology and Irvine Cancer Research Center, Columbia University
Career Start Year 1988
Number of shared co-authors 6
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Spanish National Cancer Research Centre-CNIO
Career Start Year 1983
Number of shared co-authors 1
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Career Start Year 1983
Number of shared co-authors 28
Korea Advanced Institute of Science and Technology (KAIST)
Career Start Year 1982
Number of shared co-authors 0

Collaborators

Centro Hospitalar Universitario de Sao Joao.
Co-authored papers 22
University of British Columbia
Co-authored papers 5
Co-authored papers 5
University of British Columbia
Co-authored papers 4
Royal Adelaide Hospital
Co-authored papers 2
University of British Columbia
Co-authored papers 2
University of Adelaide
Co-authored papers 2
University of British Columbia
Co-authored papers 2
Royal Brisbane and Women's Hospital
Co-authored papers 2
QIMR Berghofer Medical Research Institute
Co-authored papers 2
University of Queensland
Co-authored papers 2
QIMR Berghofer Medical Research Institute
Co-authored papers 2
The Queensland Institute of Medical Research
Co-authored papers 2
South Australian Health and Medical Research Institute
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
QIMR Berghofer Medical Research Institute
Co-authored papers 1
QIMR Berghofer Medical Research Institute
Co-authored papers 1
University of Queensland
Co-authored papers 1
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 1
Ferdowsi University of Mashhad
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
QIMR Berghofer Medical Research Institute
Co-authored papers 1
QIMR Berghofer Medical Research Institute
Co-authored papers 1
The Peter Doherty Institute for Infection and Immunity, The University of Melbourne
Co-authored papers 1
Mater Research Institute - University of Queensland
Co-authored papers 1
National Institutes of Health, National Cancer Institute, Center for Cancer Research
Co-authored papers 1
NorthShore University HealthSystem
Co-authored papers 1
Peter MacCallum Cancer Centre
Co-authored papers 1